2-Butenedioic acid, (Z)-, ion(1-), 1,4-bis(2-chloroethyl)-1,4-diazoniabicyclo(2.2.1)heptane (2:1) (9CI)

Modify Date: 2024-09-17 18:47:00

2-Butenedioic acid, (Z)-, ion(1-), 1,4-bis(2-chloroethyl)-1,4-diazoniabicyclo(2.2.1)heptane (2:1) (9CI) Structure
2-Butenedioic acid, (Z)-, ion(1-), 1,4-bis(2-chloroethyl)-1,4-diazoniabicyclo(2.2.1)heptane (2:1) (9CI) structure
Common Name 2-Butenedioic acid, (Z)-, ion(1-), 1,4-bis(2-chloroethyl)-1,4-diazoniabicyclo(2.2.1)heptane (2:1) (9CI)
CAS Number 73387-70-9 Molecular Weight 340.22300
Density N/A Boiling Point N/A
Molecular Formula C13H21Cl2N2O4+ Melting Point N/A
MSDS N/A Flash Point N/A

 Names

Name 1,4-Diazoniabicyclo[2.2.1]heptane, 1,4-bis(2-chloroethyl)-, (Z)-2-butenedioate (1_1)

 Chemical & Physical Properties

Molecular Formula C13H21Cl2N2O4+
Molecular Weight 340.22300
Exact Mass 339.08800
PSA 77.43000

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
HM8100000
CAS REGISTRY NUMBER :
73387-70-9
LAST UPDATED :
198909
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C9-H18-Cl2-N2.2C4-H3-O4

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
746 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) Volume(issue)/page/year: JAN1986
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
210 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) Volume(issue)/page/year: JAN1986
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
73290 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) Volume(issue)/page/year: JAN1986